TransMedics $TMDX Surges: Q2 Revenue Beats, EPS Doubles, Guidance Raised
Key Takeaways TransMedics significantly surpassed Q2 2025 expectations, reporting revenue of $157.4 million against a $148 million forecast and an EPS of $0.92, more than double the anticipated $0.43. The...